Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04804059 | A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males | ||
| NCT01535547 | Drug Interaction Study of Isavuconazole and Tacrolimus | ||
| NCT00529282 | A Study of Ceftobiprole in Patients With Fever and Neutropenia. | ||
| NCT01651325 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects | ||
| NCT03230318 | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma | ||
| NCT01026740 | Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers | ||
| NCT01245140 | Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis | ||
| NCT00228982 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT00965042 | Effect of Ceftobiprole on Human Intestinal Microflora | ||
| NCT01406171 | Drug Interaction Study of Isavuconazole and Midazolam | ||
| NCT01635972 | Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion | ||
| NCT05856227 | Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age | ||
| NCT01752920 | Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations | ||
| NCT00210964 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT05527834 | Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants | ||
| NCT01809860 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects | ||
| NCT04240886 | Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds | ||
| NCT00771719 | Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia | ||
| NCT01657838 | Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects | ||
| NCT07500181 | A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects | ||
| NCT00505258 | Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia | ||
| NCT00412893 | Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis | ||
| NCT03241550 | A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | ||
| NCT04098692 | Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects | ||
| NCT00124475 | Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis | ||
| NCT03439124 | Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia | ||
| NCT01494597 | Drug Interaction Study of Isavuconazole and Cyclosporine | ||
| NCT06665555 | Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age | ||
| NCT04314206 | VNRX-5024 Safety and PK in Healthy Adult Volunteers | ||
| NCT02956499 | Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects | ||
| NCT02895360 | Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma | ||
| NCT01711489 | A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects | ||
| NCT01565720 | Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization | ||
| NCT01555918 | A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers | ||
| NCT01635946 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin | ||
| NCT00413218 | Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections | ||
| NCT02490800 | Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma | ||
| NCT04087876 | Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | ||
| NCT00519675 | Alitretinoin in the Treatment of Chronic Hand Eczema | ||
| NCT06961708 | A Study of Fosmanogepix in Healthy Adult Chinese Subjects | ||
| NCT01711827 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects | ||
| NCT00771524 | Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone | ||
| NCT06733675 | Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination | ||
| NCT04148287 | An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris | ||
| NCT05582187 | A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function. | ||
| NCT06925321 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. | ||
| NCT05488678 | Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function | ||
| NCT01597986 | Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone | ||
| NCT00309621 | Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis | ||
| NCT00326287 | Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia |
